Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
Description
The objective of this review was to examine the latest literature regarding the effectiveness of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient populations. COVID-19 is highly transmissible with potentially
